Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell anti-viral Remdesivir drug to fight COVID-19 - ANI News 21-Jun-2020

on

Domestic pharma giants-- Cipla, Hetero got DCGI's nod to manufacture, sell anti-viral Remdesivir drug to fight COVID-19 - ANI News


New Delhi [India], June 21 (ANI): In a significant development, India's top drug regulator has given nod to two domestic pharmaceutical companies--Cipla and Hetero for marketing authorization of anti-viral drug Remdesivir only for "restricted emergency use" o…

More...